News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Luigi Formisano: It Was a Great Pleasure to Take Part in This Amazing Meeting
Luigi Formisano/LinkedIn
May 17, 2025, 20:13

Luigi Formisano: It Was a Great Pleasure to Take Part in This Amazing Meeting

Luigi Formisano, Associate Professor of Medical Oncology at University of Naples Federico II, shared on LinkedIn:

“It was a great pleasure to take part in this amazing meeting organized by Ciro Imbimbo and Savio Domenico Pandolfo
The multidisciplinary approach is the key to success in the fight against cancer. Well done, everyone!”

Luigi Formisano

cancer Ciro Imbimbo Luigi Formisano OncoDaily Oncology Savio Domenico Pandolfo
Special Coverage
Blog
May 17, 2025, 20:13
Luigi Formisano: It Was a Great Pleasure to Take Part in This Amazing Meeting
Blog
May 17, 2025, 20:03
Zainab Shinkafi-Bagudu: 2025 Cancer Planners Forum Has United Stakeholders to Strengthen Cancer Control Policies
Blog
May 17, 2025, 19:44
XV Meet-URO Meeting Concludes After Two Days of Scientific Exchange
Blog
May 17, 2025, 19:16
Nikos Papandreou Outlines His Bold Vision for a More Equitable and Innovation-Driven Approach to Cancer Care in CancerWorld Interview
Science
May 17, 2025, 17:38
Chiara Corti: Decoding Clinical Trials in Metastatic Breast Cancer - Practical Insights for Optimal Therapy Sequencing
Blog
May 17, 2025, 17:27
Raffaella Casolino: Attending the 1st Cancer Planners Forum was One of the Most Incredible Experiences of my Career
Blog
May 17, 2025, 17:21
Paolo Tarantino Highlights Real-World Data on ADC Sequencing in Breast Cancer
Blog
May 17, 2025, 16:10
Aruni Ghose Shared Survey on Cancer Patient Engagement and MDT Awareness
Blog
May 17, 2025, 15:37
Mark Lawler Launches Report on Data-Driven Cancer Innovation in Ireland
Blog
May 17, 2025, 15:36
Rasha Aboelhassan: Should we Give Chemotherapy with Immunotherapy as a Neoadjuvant Setting in stage I TNBC?
Blog
May 17, 2025, 15:28
Yakup Ergün: Great Debate on Continuing CDK4/6 After Progression
Oncolibrary
May 17, 2025, 15:23
SGNTUC-019 Trial Final Results: Tucatinib + Trastuzumab Shows Durable Benefit in HER2-Mutant MBC at ESMO 2025